Clinical Trial Update: Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on safety and efficacy of combining bevacizumab with the NaviFUS system for recurrent glioblastoma multiforme, currently recruiting in P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• NaviFUS System

Snippet

Sponsor: NaviFUS Corporation | Conditions: Glioblastoma Multiforme, Glioblastoma | Phase 1, Phase 2 | Status: RECRUITING